D2-receptor-linked signaling pathways regulate the expression of hepatic CYP2E1

Life Sciences

Volumn 82, Issue 1-2, 2008, Pages 1-10

  Konstandi, Maria ^a   Harkitis, Panagiotis ^a   Kostakis, Dimitris ^a   Marselos, Marios ^a   Johnson, Elizabeth O ^a   Lang, Matti A ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Catecholamines; CYP2E1; D2 receptors; Dopamine; Insulin; Rat

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ATIPAMEZOLE; BENSERAZIDE; BENZO[A]PYRENE; BROMOCRIPTINE; CATECHOLAMINE; CYTOCHROME P450 2E1; DEXMEDETOMIDINE; DOPAMINE 2 RECEPTOR; GUANETHIDINE; ISOPRENALINE; LEVODOPA; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; RESERPINE; SULPIRIDE; ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG METABOLISM; ENZYME ACTIVATION; LIVER METABOLISM; MALE; METABOLIC RATE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM; ANIMAL; BIOSYNTHESIS; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; LIVER; METABOLISM; UPREGULATION; WESTERN BLOTTING; WISTAR RAT;

RATTUS;

ANIMALS; BENZO(A)PYRENE; BLOTTING, WESTERN; CATECHOLAMINES; CYTOCHROME P-450 CYP2E1; DOWN-REGULATION; ISOENZYMES; LIVER; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 37049019854     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.09.026     Document Type: Article

References (48)

1. Barbeau A., and Roy M. Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease. Neurology 26 5 (1976) 399-404
2. Benarroch E.E., Schmelzer J.D., Ward K.K., Nelson D.K., and Low P.A. Noradrenergic and neuropeptide mechanisms in guanethidine-sympathectomized rats. American Journal of Physiology 2 2pt 2 (1990) R371-R375
3. 1 receptors in the control of growth hormone secretion in the rat. Journal of Endocrinology 127 2 (1990) 191-196
4. 2-receptor: new surprises from an old friend. Neuron 47 3 (2005) 335-338
5. Chen G.F., Ronis M.J., Ingelman-Sundberg M., and Badger T.M. Hormonal regulation of microsomal cytochrome P4502E1 and P450 reductase in rat liver and kidney. Xenobiotica 29 5 (1999) 437-451
6. Cooper J.R., Bloom F.E., and Roth R.H. Norepinephrine and epinephrine. In: House J. (Ed). The Biochemical Basis of Neuropharmacology. Seventh Edition (1996), Oxford University Press, New York 226-292
7. Craig T.J., and Lin S.P. Cancer and mental illness. Comprehensive Psychiatry 22 4 (1981) 404-410
8. Czarnecki A. Protective effect of inosine on adrenaline-induced myocardial necrosis. Pharmacological Research Communications 18 (1986) 459-469
9. Daunt D.A., Hurt C., Hein L., Kallio J., Feng F., and Kobilka B.K. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Molecular Pharmacology 51 5 (1997) 711-720
10. Dong Z.G., Hong J.Y., Ma Q.A., Li D.C., Bullock J., Gonzalez F.J., Park S.S., Gelboin H.V., and Yang C.S. Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Archives of Biochemistry and Biophysics 263 1 (1988) 29-35
11. 2-adrenergic signalling in rat pancreatic islets. Cellular Signalling 10 9 (1998) 637-643
12. Gomperts B.D., Kramer I.M., and Tatham P.E.R. . Receptors. In: Gomperts B.D., Kramer I.M., and Tatham P.E.R. (Eds). Signal Transduction. Fourth Edition (2004), Elsevier Academic Press, London 33-38
13. Gonzalez F.J., Ueno T., Umeno M., Song B.J., Veech R.L., and Gelboin H.V. Microsomal ethanol oxidizing system: transcriptional and posttranscriptional regulation of cytochrome P450, CYP2E1. Alcohol and Alcoholism. Supplement 1 (1991) 97-101
14. Gonzalez F.J. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutation Research 569 (2005) 101-110
15. Guengerich E.P. Cytochrome P450, drugs, and diseases. Molecular Interventions 3 4 (2003) 194-204
16. Holloway M.G., Laz E.V., and Waxman D.J. Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4alpha. Molecular Endocrinology 20 3 (2006) 647-660
17. Ingelman-Sundberg M. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedeberg's Archives of Pharmacology 369 1 (2004) 89-104
18. Konstandi M., Kostakis D., Johnson E.O., Lang M.A., and Marselos M. Noradrenergic stimulation modulates CYP2E1 regulation in rats. Fundamental & Clinical Pharmacology Suppl 13 1 (1999) 348s
19. Konstandi M., Johnson E.O., Marselos M., Kostakis D., Fotopoulos A., and Lang M.A. Stress-mediated modulation of B(α)P-induced hepatic CYP1A1: role of catecholamines. Chemico-Biological Interactions 147 (2004) 65-77
20. Konstandi M., Kostakis D., Harkitis P., Marselos M., Johnson E.O., Adamidis K., and Lang M.A. Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression. Biochemical Pharmacology 69 2 (2005) 277-287
21. Konstandi M., Kostakis D., Harkitis P., Johnson E.O., Marselos M., Adamidis K., and Lang M.A. Benzo(alpha)pyrene-induced up-regulation of CYP1A2 gene expression: role of adrenoceptor-linked signaling pathways. Life Sciences 79 4 (2006) 331-334
22. 2-adrenoceptors. Biochemical Pharmacology 67 (2004) 87-96
23. Lang M.A., Gielen J.E., and Nebert D.W. Genetic evidence for many unique liver microsomal P-450 mediated monoxygenase activities in heterogeneic stock mice. Journal of Biological Chemistry 256 23 (1981) 12068-12075
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randal R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
25. Mattheij J.A., Brouwer G.M., Hanstede J.G., and Swarts J.J. No evidence for a peripheral effect of l-DOPA on plasma prolactin in the rat. Life Sciences 31 9 (1982) 915-921
26. Mefford I.N. Application of high performance chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. Journal of Neuroscience Methods 3 (1981) 207-224
27. Moncion A., Truong N.T., Garrone A., Beaune P., Barouki R., and De Waziers I. Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin. Journal of Biological Chemistry 277 48 (2002) 45904-45910
28. Mortensen P.B. The incidence of cancer in schizophrenic patients. Journal of Epidemiology and Community Health 43 1 (1989) 43-47
29. Novak R.F., and Woodcroft K.J. The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Archives of Pharmacal Research 23 4 (2000) 267-282
30. Pelkonen O., and Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacological Reviews 34 (1982) 189-222
31. Peng H.M., and Coon M.J. Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone. Molecular Pharmacology 54 4 (1998) 740-747
32. Pritchard T.C., and Alloway K.D. Cellular neuroscience. In: Edwards J., and Arlotto M. (Eds). Medical Neuroscience (1999), Fence Creek Publishing, LLC, Madison, Connecticut 38
33. Rassidakis N.C., Kelepouris M., Goulis K., and Karaiossefidis K. On the incidence of malignancy among schizophrenic patients. Agressologie 14 4 (1973) 269-273
34. Reinke L.A., and Moyer M.J. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metabolism and Disposition 13 5 (1985) 548-552
35. Rice D. No lung cancer in schizophrenia?. British Journal of Psychiatry 134 (1979) 128
36. 2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. Journal of Biological Chemistry 280 44 (2005) 36824-36832
37. Scheinin H., and Scheinin M. Repetitive measurement of monoamine metabolite levels in cerebrospinal fluid of conscious rats: effects of reserpine and haloperidol. European Journal of Pharmacology 113 (1985) 345-351
38. Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., and Uhler M.D. Catecholamines. In: Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., and Uhler M.D. (Eds). Basic Neurochemistry. Sixth Edition (1998), Lippincott-Raven Publishers, New York 244
39. Stephanou P., Konstandi M., Pappas P., and Marselos M. Alterations in central monoaminergic neurotransmission induced by polycyclic aromatic hydrocarbons in rats. European Journal of Drug Metabolism and Pharmacokinetics 23 (1998) 475-481
40. Thummel K.E., and Schenkman J.B. Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Molecular Pharmacology 37 1 (1990) 119-129
41. Tsigos C., and Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research 53 4 (2002) 865-871
42. Tuomisto J., and Mannisto P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacological Reviews 37 (1985) 249-332
43. Virtanen R. Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Veterinaria Scandinavica Suppl. 85 (1989) 29-37
44. Woodcroft K.J., Hafner M.S., and Novak R.F. Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology 35 2 (2002) 263-273
45. Waxman D.J., and O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Molecular Endocrinology 20 11 (2006) 2613-2629
46. Waxman D.J., Morrissey J.J., and Leblanc G.A. Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase. Molecular Pharmacology 35 4 (1989) 519-525
47. Yamazoe Y., Shimada M., Murayama N., and Kato R. Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. Journal of Biological Chemistry 262 15 (1987) 7423-7428
48. Zerilli A., Ratanasavanh D., Lucas D., Goasduff T., Dreano Y., Menard C., Picart D., and Berthou F. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chemical Research inToxicology 10 10 (1997) 1205-1212